Home » Merck Anticipates Shortage of Hepatitis B Vaccine Recombivax HB
Merck Anticipates Shortage of Hepatitis B Vaccine Recombivax HB
Merck expects an interruption of U.S. supplies this month for Recombivax HB, the adult formulation of its hepatitis B vaccine. The vaccine supply for adults probably will be depleted during the first quarter of this year, but the company does not foresee any effect on the pediatric formulation, according to a Centers for Disease Control and Prevention website on vaccine shortages.
Drug Industry Daily
Drug Industry Daily
Upcoming Events
-
25Apr
-
07May
-
14May
-
30May